All filters
Slidesets
Value of Adding Recombinant Antigens to Viral Vector Vaccines - Ventzi Vassilev, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Second Generation CAMs Leading to HBsAg Decline - Matthew McClure, MD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Next Generation CAMs, New Life for Small Molecules? - Mark Sulkowski, MD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Latest Updates on Novel Biomarkers in HBV Cure - Man-Fung Yuen, MBBS, MD, PhD, DSc
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Immunological Profiles Induced by New Therapeutic Vaccines - Eleanor Barnes, PhD, FRCP, F Med Sci
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Expanding CHB Treatment Criteria with Nucs as Prelude of Novel Curative Therapies? - Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Efficacy and Safety of Targeting PD-L1 with Monoclonal Antibodies - Jinzi J. Wu, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Durability of Response After DAA Therapies - Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Does siRNA Restore Host Control and Could it Lead to Sustained HBsAg Suppression? - Michael J. Sofia, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Discrimination of Integrated vs. cccDNA Derived HBsAg - Chloe Thio, MD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Bepirovirsen in Combination with Peg-IFN and Other Molecules - Stuart Kendrick, MD, PhD, MRCP
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Balance of Response and Adverse Events in Immunotherapy for CHB - Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Are We Only Able to Suppress HDV or is Cure in Reach? - Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Anti-HBs Monoclonal Antibodes in Nuc-naïve and Combo Therapies - Carey Hwang, MD, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Bulevirtide - Data from Real World Usage after Approval in Europe - John Flaherty
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Development of Assembly Next Generation Core Inhibitors - Grace Wang
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Evidence of T Cell Restoration after siRNA Therapy - Emily Thi
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Cam-N Jnj-6379. Lessons Learned From Reef-1 and -2 Studies - Michael Biermer
Presented at:
International Workshop on HBV Cure 2022
Slidesets
How HBV RNA and HBcrAg Relate to cccDNA Transcriptional Activity - Barbara Testoni
Presented at:
International Workshop on HBV Cure 2022
Slidesets
HBV-Specific T Cell Profile Associated with Functional Cure - Georg Lauer
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Why We Should Be Careful Using NA Withdrawal as a Therapeutic Option - Pietro Lampertico
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Therapy Induced Flares Associated With HBsAg Decline - Man-Fung Yuen
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Toxicity Profiles of Checkpoint Inhibition, What to Expect and When to Be Concerned - Morven Cunningham
Presented at:
International Workshop on HBV Cure 2022